Induction of cytotoxicity from fresh splenocytes after in vivo administration of cyclophosphamide. Importance of long-term culture with high-dose recombinant interleukin-2 (Q69447291)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 1989

Language	Label	Description	Also known as
English	Induction of cytotoxicity from fresh splenocytes after in vivo administration of cyclophosphamide. Importance of long-term culture with high-dose recombinant interleukin-2	scientific article published on 01 January 1989

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2624921%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

Induction of cytotoxicity from fresh splenocytes after in vivo administration of cyclophosphamide. Importance of long-term culture with high-dose recombinant interleukin-2 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2624921%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

author name string

R Kim

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2624921%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

R Lafreniere

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2624921%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

K Borkenhagen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2624921%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

L D Bryant

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2624921%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

publication date

1 January 1989

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2624921%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2624921%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2624921%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2624921%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

283-288

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2624921%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

https://scigraph.springernature.com/pub.10.1007/bf01744895

0 references

Differential effects of cyclophosphamide on the B and T cell compartments of adult mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological Activity of Recombinant Human Interleukin-2 Produced inEscherichia coli

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure and expression of a cloned cDNA for human interleukin-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

„Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer (LAK) cells. I. Differential recovery of LAK, natural killer cells, and cytotoxic T lymphocytes after a sublethal dose of cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Over-all tracer studies with C14 labeled nitrogen mustard in normal and leukemic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined effects of chemotherapy and interleukin 2 in the therapy of mice with advanced pulmonary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/2624921

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q69447291&oldid=1753412378"